Accelerate Diagnostics (axdx 5 12/15/26)
13F holders, Q1 2024 (March 31)1holders
$0.53avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Accelerate Diagnostics (axdx 5 12/15/26) in their 13F filings. The largest holder was Wolverine Asset Management LLC ($2.2M).
- Company
- Accelerate Diagnostics (axdx 5 12/15/26)
- CUSIP
- 00430HAC6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Wolverine Asset Management LLC | 0.20% | No change | 4,178,560 | $2.2M |
"% of holder's portfolio" is ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26)'s weight in each manager's 13F, not the share of Accelerate Diagnostics (axdx 5 12/15/26) the manager owns.